Curative Biotechnology (CUBT)
OTHER OTC:CUBT
Total Valuation
Curative Biotechnology has a market cap or net worth of $10.57M. The enterprise value is $10.62M.
Market Cap$10.57M
Enterprise Value$10.62M
Share Statistics
Curative Biotechnology has 6,819,907 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding6,819,907
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Curative Biotechnology’s return on equity (ROE) is 0.37 and return on invested capital (ROIC) is 31.76%.
Return on Equity (ROE)0.37
Return on Assets (ROA)-1.07
Return on Invested Capital (ROIC)31.76%
Return on Capital Employed (ROCE)0.25
Revenue Per Employee0.00
Profits Per Employee-565.77K
Employee Count4
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Curative Biotechnology is ―. Curative Biotechnology’s PEG ratio is 3.66.
PE Ratio―
PS Ratio0.00
PB Ratio-135.42
Price to Fair Value-135.42
Price to FCF-948.65
Price to Operating Cash Flow-30.77
PEG Ratio3.66
Income Statement
In the last 12 months, Curative Biotechnology had revenue of 0.00 and earned -2.26M in profits. Earnings per share was >-0.01.
Revenue0.00
Gross Profit-87.84K
Operating Income-1.50M
Pretax Income-2.26M
Net Income-2.26M
EBITDA-1.41M
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was -193.12K and capital expenditures 0.00, giving a free cash flow of -193.12K billion.
Operating Cash Flow-193.12K
Free Cash Flow-193.12K
Free Cash Flow per Share-0.03
Dividends & Yields
Curative Biotechnology pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.88
52-Week Price Change-11.63%
50-Day Moving Average1.25
200-Day Moving Average―
Relative Strength Index (RSI)54.15
Average Volume (3m)181.23K
Important Dates
Curative Biotechnology upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Curative Biotechnology as a current ratio of 0.01, with Debt / Equity ratio of -22.00%
Current Ratio0.01
Quick Ratio0.01
Debt to Market Cap<0.01
Net Debt to EBITDA-0.93
Interest Coverage Ratio-1.50
Taxes
In the past 12 months, Curative Biotechnology has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Curative Biotechnology EV to EBITDA ratio is -583.76, with an EV/FCF ratio of -950.16.
EV to Sales0.00
EV to EBITDA-583.76
EV to Free Cash Flow-950.16
EV to Operating Cash Flow-950.16
Balance Sheet
Curative Biotechnology has $44.80K in cash and marketable securities with $1.39M in debt, giving a net cash position of -$1.34M billion.
Cash & Marketable Securities$44.80K
Total Debt$1.39M
Net Cash-$1.34M
Net Cash Per Share-$0.20
Tangible Book Value Per Share>-$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Curative Biotechnology is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―